This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (16)
-
November 12, 2025 | Comment I-MAK's Tahir Amin presses US Congress on effect of patents on drug prices
...Critics, which include notable IP groups such as the Council for Innovation Promotion (C4IP), often point...
Sections: Intellectual Property
-
October 22, 2025 | Insight Drug price concerns motivate US patent reform efforts
...for Innovation Promotion, or C4IP, said in a statement to MLEx that the I-MAK survey is “distorting...
Sections: Intellectual Property
-
October 08, 2025 | Insight Patent eligibility reform 'top priority,' Tillis says in US Senate hearing
...for Innovation Promotion, or C4IP, which backs PERA — testified that the four Supreme Court decisions...
Sections: Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login